- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 05-06-2026: Press Release
05-06-2026 | 08:48 am
05-06-2026 | 08:48 am
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials".
No comments yet. Be the first to comment!